It’s that time of the year when air pollution dominates headlines and WhatsApp groups. Firecrackers, the kharif-to-rabi transition, and the onset of winter turn air pollution from a near-invisible risk into an omnipresent, existential threat.
Two shifts in air pollution in recent years have broadened the conversation. Now, air pollution is:
- a pan-India problem, extending beyond Delhi-NCR and the Indo-Gangetic Plain
- increasingly a pan-year problem
Air pollution certainly doesn’t suffer from a ‘you cannot manage what you cannot measure’ problem given how widely air quality index (AQI) numbers are reported, often in real time. Besides AQI, morbidity is also rising. The 2026 edition of the Lancet Countdown report attributed 2.2 million Indian deaths to PM2.5 exposure in 2023. That’s up 77% from 2010.
Policy ineffectiveness shows in this rising spread of pollution and its toll. Could an incentive problem be at play here?
Purer Air
When people realise they’re on their own, they turn to private solutions. At the going rate, air purifiers will be as ubiquitous and normalised as water purifiers. The market for these devices, priced between ₹4,000 and ₹40,000 for home-use models, was estimated at $520 million-$580 million in 2025. It was just $30 million–$35 million in 2016, when demand was limited to a few expats, embassies, and a tiny fraction of affluent households in tier-1 cities.
By early 2026, market penetration surpassed 5% of urban households. The expected compound annual growth rate (CAGR) ranges from 15% to 30%—one of the highest among consumer appliances in India—making this a $1 billion market by 2030.
Aptly, economist Ludwig von Mises said, "The luxury of today is the necessity of tomorrow". This is usually because:
- Technology and innovation bring luxury to the masses via lower costs—for example, automobiles, mobile phones, and personal computers.
- Alongside affordability, productivity gains make adoption an easy choice. For example, electricity, indoor plumbing, or air conditioning.
In comparison, the case for air purifiers is not only more existential but also forced on people by inadequate or absent policy measures to combat air pollution (more on this in a bit).
If this forced choice was not bad enough, there’s more.
Rising Perversity
Despite repeated calls from industry lobbies and citizens, air purifiers are still taxed at 18% GST. If policy steps haven't curbed air pollution, isn’t there a compelling case for the GST Council to treat air purifiers as a necessary public health good and make them more affordable?
The high taxation is bad enough, but it gets worse if you think about it more deeply.
In a sense, the government tasked with controlling air pollution is monetising its governance failure via the growth of air purifiers.
One can make an even stronger argument for the perversity of it all. Firecrackers contribute to air pollution and respiratory disorders. At the very least, they make things extremely uncomfortable during peak use, which also coincides with cooler weather that traps the pollutants and forces them into homes. The outcome: rising air purifier sales around Diwali.
This takes the incentive disconnect to another level: a government that does not actively curb firecracker use not only earns taxes from their sale—₹70 billion from the organised sector alone—but also encourages the use of air purifiers to counter the effect of the taxed firecrackers, and earns taxes from their sale! If that wasn’t enough, the GST Council reduced the GST rate on firecrackers to 18% in November 2017 to relieve the industry (and its patrons). I am sure it is no solace to the people that both pollutants and mitigants are taxed at the same rate.
Skewed incentives
The perversity is almost as pervasive as PM2.5. Consider the treatment of pollution-related disorders.
Air pollution is an immediate and dangerous trigger for people with preexisting conditions such as asthma and chronic obstructive pulmonary disease (COPD). The use of medicines for these conditions, such as Furacort, Budecort, and Duolin, as well as antibiotics like Augmentin and inhalers, increases when air pollution rises. Related medical devices often used for respiratory conditions—such as nebulisers, oxygen concentrators, and medical-grade oxygen—also see rising sales.
Overall, sales of such respiratory medicines amounted to ₹19.50 billion in December 2025—up 10% YoY and 18% over two years—marking the highest monthly level ever recorded, according to data from market research firm Pharmarack. That makes it a nearly $3 billion market in annual sales. These medicines and devices were subject to 12% GST rate until September 2025, when it was reduced to 5%.
In effect, the government earns from pollutants, devices that counter their effects, and treatment of pollutant-related disorders.
Hollow Policy
Since the status quo is not an option for any government, hesitant steps, short-term solutions, and media management are favoured. This includes sprinklers, odd-even policy, and public service messages rather than actual action.
Some specific policy gaps:
- The legal annual limit for PM2.5 in India is 40 µg/m³—eight times higher than the WHO’s safety guideline of 5 µg/m³
- Vast tracts outside large cities do not have pollution-monitoring systems, and there is no rural air quality policy
- Where monitored, air quality scores are manipulated or outright fudged in hilarious ways, including spraying water near AQI monitors
- India’s ambient air quality standards have not been updated since 2009, while scientific evidence and WHO guidelines have moved ahead
- The underlying calculation methodology for the national AQI has not been comprehensively reviewed or revised since its launch on Oct 1, 2014
- Maharashtra—India’s largest state—is a bizarre example. The vital state pollution control board was headed by an IAS officer until 2024. The incumbent chairman is a builder-politician.
It may be a stretch to say the government would rather tax gains from the pollution economy than undertake painful reforms to solve the problem. The economic cost of lost productivity and early deaths—9-9.5% of GDP, per FICCI-EY estimates—is massive, and the nation’s image suffers.
However, the incentives and optics are problematic, especially in a country with a track record of band-aid fixes for serious public health concerns. At the very least, the government can stop profiting from a problem it has been unable—or unwilling—to control.